Probing the interface between factor Xa and tissue factor in the quaternary complex tissue factor-factor VIIa-factor Xa-tissue factor pathway inhibitor

被引:22
作者
Carlsson, K [1 ]
Freskgård, PO
Persson, E
Carlsson, U
Svensson, M
机构
[1] Linkoping Univ, IFM, Dept Chem, SE-58183 Linkoping, Sweden
[2] Novo Nordisk AS, Prot Biotechnol, DK-2880 Bagsvaerd, Denmark
[3] Novo Nordisk AS, Haemostasis Biol, Malov, Denmark
来源
EUROPEAN JOURNAL OF BIOCHEMISTRY | 2003年 / 270卷 / 12期
关键词
fluorescence; local probing; protein-protein interactions; site-directed labeling;
D O I
10.1046/j.1432-1033.2003.03625.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Blood coagulation is triggered by the formation of a complex between factor VIIa (FVIIa) and its cofactor, tissue factor (TF). TF-FVIIa is inhibited by tissue factor pathway inhibitor (TFPI) in two steps: first TFPI is bound to the active site of factor Xa (FXa), and subsequently FXa-TFPI exerts feedback inhibition of TF-FVIIa. The FXa-dependent inhibition of TF-FVIIa activity by TFPI leads to formation of the quaternary complex TF-FVIIa-FXa-TFPI. We used site-directed fluorescence probing to map part of the region of soluble TF (sTF) that interacts with FXa in sTF-FVIIa-FXa-TFPI. We found that the C-terminal region of sTF, including positions 163, 166, 200 and 201, is involved in binding to FXa in the complex, and FXa, most likely via its Gla domain, is also in contact with the Gla domain of FVIIa in this part of the binding region. Furthermore, a region that includes the N-terminal part of the TF2 domain and the C-terminal part of the TF1 domain, i.e. the residues 104 and 197, participates in the interaction with FXa in the quaternary complex. Moreover, comparisons of the interaction areas between sTF and FX(a) in the quaternary complex sTF-FVIIa-FXa-TFPI and in the ternary complexes sTF-FVII-FXa or sTF-FVIIa-FX demonstrated large similarities.
引用
收藏
页码:2576 / 2582
页数:7
相关论文
共 37 条
[21]   Properties of spin and fluorescent labels at a receptor-ligand interface [J].
Owenius, R ;
Österlund, M ;
Lindgren, M ;
Svensson, M ;
Olsen, OH ;
Persson, E ;
Freskgård, PO ;
Carlsson, U .
BIOPHYSICAL JOURNAL, 1999, 77 (04) :2237-2250
[22]   Spin and fluorescent probing of the binding interface between tissue factor and factor VIIa at multiple sites [J].
Owenius, R ;
Österlund, M ;
Svensson, M ;
Lindgren, M ;
Persson, E ;
Freskgård, PO ;
Carlsson, U .
BIOPHYSICAL JOURNAL, 2001, 81 (04) :2357-2369
[23]   STRUCTURE OF HUMAN DES(1-45) FACTOR-XA AT 2.2-ANGSTROM RESOLUTION [J].
PADMANABHAN, K ;
PADMANABHAN, KP ;
TULINSKY, A ;
PARK, CH ;
BODE, W ;
HUBER, R ;
BLANKENSHIP, DT ;
CARDIN, AD ;
KISIEL, W .
JOURNAL OF MOLECULAR BIOLOGY, 1993, 232 (03) :947-966
[24]  
PETERSEN JGL, 1993, J BIOL CHEM, V268, P13344
[25]   Structure of human factor VIIa and its implications for the triggering of blood coagulation [J].
Pike, ACW ;
Brzozowski, AM ;
Roberts, SM ;
Olsen, OH ;
Persson, E .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (16) :8925-8930
[26]   TISSUE FACTOR RESIDUES LYS(165) AND LYS(166) ARE ESSENTIAL FOR RAPID FORMATION OF THE QUATERNARY COMPLEX OF TISSUE-FACTOR-CENTER-DOT-VIIA WITH XA-CENTER-DOT-TISSUE FACTOR PATHWAY INHIBITOR [J].
RAO, LVM ;
RUF, W .
BIOCHEMISTRY, 1995, 34 (34) :10867-10871
[27]   Studies of the activation of factor VII bound to tissue factor [J].
Rao, LVM ;
Williams, T ;
Rapaport, SI .
BLOOD, 1996, 87 (09) :3738-3748
[28]   THE 3RD TRP-LYS-SER (WKS) TRIPEPTIDE MOTIF IN TISSUE FACTOR IS ASSOCIATED WITH A FUNCTION SITE [J].
REHEMTULLA, A ;
RUF, W ;
MILES, DJ ;
EDGINGTON, TS .
BIOCHEMICAL JOURNAL, 1992, 282 :737-740
[29]  
ROY S, 1991, J BIOL CHEM, V266, P22062
[30]  
RUF W, 1992, J BIOL CHEM, V267, P6375